Eskayef Bangladesh Limited, a successor of world-renowned multinational pharmaceutical company, SmithKline & French (SK&F), USA was acquired by TRANSCOM in 1990 in the wake of the merger between SmithKline & French, USA and Beecham, UK. TRANSCOM is one of the leading and fastest growing business conglomerates in Bangladesh. Like TRANSCOM, not many industrial groups in Bangladesh can claim a history of continuous business pursuits stretching back over 100 years. Over the time, its early industrial ventures have moved over to businesses involved in high-tech manufacturing, international trading and distribution, forming strong ties with a host of blue chip multinational companies.

After the acquisition of SK&F by TRANSCOM, the new company was named – Eskayef Bangladesh Limited and it has subsequently culminated to become one of the leading pharmaceutical companies of Bangladesh. Rapid business growth since its inception have propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today.

Mission
To manufacture & supply products with quality and excellency & to contribute to improve the population’s health & well-being.

Vision
To lead the national pharmaceutical market, to be recognized as a multinational conglomerate from Bangladesh and stand out as a model of efficiency & trust to their collaborators, consumers, health care professionals & society.

Quality Approach

Eskayef believes that pharmaceutical business is built solely on the blocks of trust and it takes perseverance for a pharmaceutical business entity to earn the trust of the people. Many global best practices are being cultured in the everyday activities of Eskayef, which are contributing in a big way to shape up its future & earning people’s trust.